CH505839A - Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten - Google Patents

Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten

Info

Publication number
CH505839A
CH505839A CH292370A CH292370A CH505839A CH 505839 A CH505839 A CH 505839A CH 292370 A CH292370 A CH 292370A CH 292370 A CH292370 A CH 292370A CH 505839 A CH505839 A CH 505839A
Authority
CH
Switzerland
Prior art keywords
preparation
optically active
piperazine derivatives
active piperazine
new racemic
Prior art date
Application number
CH292370A
Other languages
English (en)
Inventor
Anton Dr Mentrup
Karl Dr Zeile
Peter Dr Danneberg
Kurt Dr Schromm
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1966B0088772 external-priority patent/DE1670144B2/de
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CH505839A publication Critical patent/CH505839A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH292370A 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten CH505839A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1966B0088772 DE1670144B2 (de) 1966-09-03 1966-09-03 Substituierte n- eckige klammer auf l-arylpropyl-(2) eckige klammer zu -n'- phenyl-piperazine, verfahren zu deren herstellung und daraus hergestellte zentraldepressiv wirkende pharmazeutische praeparate
DEB0093758 1967-08-01

Publications (1)

Publication Number Publication Date
CH505839A true CH505839A (de) 1971-04-15

Family

ID=25968081

Family Applications (8)

Application Number Title Priority Date Filing Date
CH292270A CH505838A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH1127167A CH506532A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292570A CH517751A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292170A CH505837A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292670A CH505841A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292470A CH505840A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292070A CH507964A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292370A CH505839A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten

Family Applications Before (7)

Application Number Title Priority Date Filing Date
CH292270A CH505838A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH1127167A CH506532A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292570A CH517751A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292170A CH505837A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292670A CH505841A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292470A CH505840A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH292070A CH507964A (de) 1966-09-03 1967-08-10 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten

Country Status (14)

Country Link
US (1) US3729474A (de)
AT (7) AT280303B (de)
BE (1) BE703407A (de)
CH (8) CH505838A (de)
DE (1) DE1670254A1 (de)
DK (1) DK124081B (de)
ES (8) ES344693A1 (de)
FI (1) FI49969C (de)
FR (2) FR1550188A (de)
GB (1) GB1176672A (de)
IL (1) IL28589A (de)
NL (2) NL6712054A (de)
SE (1) SE350260B (de)
YU (9) YU33749B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2037852C3 (de) * 1970-07-30 1980-06-26 Boehringer Sohn Ingelheim Neue Piperazinderivate und Verfahren zu ihrer Herstellung
US3859438A (en) * 1971-07-08 1975-01-07 Boehringer Sohn Ingelheim Pharmaceutical compositions containing an n-(1-bicyclic aryl-propyl-2)-n-bicyclic aryl-piperazine and method of use
DE2325633A1 (de) * 1973-05-21 1974-12-12 Boehringer Sohn Ingelheim Piperazinderivate
US4094980A (en) * 1974-09-03 1978-06-13 Boehringer Ingelheim Gmbh N-[1-(3',4'-methylenedioxy-phenyl)-propyl-(2)]-N'-phenyl-piperazines and salts thereof
FR2285883A1 (fr) * 1974-09-30 1976-04-23 Cerm Cent Europ Rech Mauvernay Nouveaux composes chimiques a activite bronchospasmolytique et antitussive, et procede pour leur obtention
US4130646A (en) * 1975-07-25 1978-12-19 E. R. Squibb & Sons, Inc. 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof
FI60479C (fi) * 1977-12-22 1982-02-10 Serlachius Oy Planteringsanordning
US4684651A (en) * 1981-03-17 1987-08-04 Mitsubishi Chemical Industries Limited Alkylenedioxybenzene and acid addition salts thereof useful as hypotensives
US4891375A (en) * 1988-01-13 1990-01-02 Pfizer Inc. Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
JP4108747B2 (ja) * 1995-07-13 2008-06-25 アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 治療薬としてのピペラジン誘導体
FR2737724B1 (fr) * 1995-08-09 1997-09-05 Synthelabo Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
US20070219213A1 (en) * 2004-05-20 2007-09-20 Soares Romeiro Luiz A Use of Adrenergic N-Phenylpiperazine Antagonists, Pahrmaceutical Compositions Containning Them, and Methods of Preparing Them

Also Published As

Publication number Publication date
NL6712054A (de) 1968-03-04
SE350260B (de) 1972-10-23
YU123975A (en) 1983-04-27
YU123375A (en) 1983-04-27
ES359159A1 (es) 1970-05-16
BE703407A (de) 1968-03-01
AT280289B (de) 1970-04-10
YU123675A (en) 1983-04-27
CH505838A (de) 1971-04-15
CH506532A (de) 1971-04-30
AT280304B (de) 1970-04-10
YU37322B (en) 1984-08-31
CH505841A (de) 1971-04-15
YU37326B (en) 1984-08-31
ES344693A1 (es) 1969-01-01
ES359162A1 (es) 1970-05-16
AT280306B (de) 1970-04-10
YU37323B (en) 1984-08-31
DK124081B (da) 1972-09-11
ES359157A1 (es) 1970-05-16
CH505840A (de) 1971-04-15
YU33749B (en) 1978-05-15
FR1550188A (de) 1968-12-20
IL28589A (en) 1972-02-29
YU37321B (en) 1984-08-31
AT280307B (de) 1970-04-10
YU37324B (en) 1984-08-31
YU37327B (en) 1984-08-31
YU172467A (en) 1977-10-31
YU123575A (en) 1983-04-27
YU123475A (en) 1983-04-27
FI49969C (fi) 1975-11-10
YU123775A (en) 1983-04-27
US3729474A (en) 1973-04-24
YU37320B (en) 1984-08-31
ES359158A1 (es) 1970-05-16
GB1176672A (en) 1970-01-07
YU123875A (en) 1983-04-27
ES359156A1 (es) 1970-05-16
CH517751A (de) 1972-01-15
AT280302B (de) 1970-04-10
AT280303B (de) 1970-04-10
FI49969B (de) 1975-07-31
AT280301B (de) 1970-04-10
ES359160A1 (es) 1970-05-16
YU37325B (en) 1984-08-31
CH507964A (de) 1971-05-31
ES359161A1 (es) 1970-05-16
FR7515M (de) 1969-12-15
CH505837A (de) 1971-04-15
YU123275A (en) 1983-04-27
NL132357C (de)
DE1670254A1 (de) 1971-01-28

Similar Documents

Publication Publication Date Title
CH512427A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-sec. -alkylaminopropanen
CH505838A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
CH510634A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH527827A (de) Verfahren zur Herstellung von neuen Piperazinderivaten
AT286293B (de) Verfahren zur Herstellung von neuen Styrylthiazoliumsalzen
AT281851B (de) Verfahren zur Herstellung von neuen Phenazinderivaten
CH471146A (de) Verfahren zur Herstellung von neuen Morpholinderivaten
AT258920B (de) Verfahren zur Herstellung von neuen substituierten Piperazinderivaten
CH484145A (de) Verfahren zur Herstellung von neuen N-substituierten Noratropiniumsalzen
AT279588B (de) Verfahren zur herstellung von neuen 2-(beta-halogenaethylamino)-5-halogenbenzophenonen
AT270081B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Scopolammoniumsalzen
CH496658A (de) Verfahren zur Herstellung von neuem racemischem oder optisch aktivem 1-(2'-Nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan
CH513812A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-sec.-alkylaminopropanen
AT264536B (de) Verfahren zur Herstellung von neuen Salzen des Chlorpromazins
CH509260A (de) Verfahren zur Herstellung von neuem racemischem oder optisch aktivem 1-(2'-Nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan
CH427817A (de) Verfahren zur Herstellung von neuen Piperazinderivaten
AT273963B (de) Verfahren zur Herstellung von neuen Thiazoliumsalzen
CH461502A (de) Verfahren zur Herstellung von neuen Piperazinderivaten
CH480360A (de) Verfahren zur Herstellung von neuen Morpholinderivaten
AT260277B (de) Verfahren zur Herstellung von neuen β -Thiosemicarbazonen oder Salzen davon
AT270861B (de) Verfahren zur Herstellung von Penicillinsalzen
CH537900A (de) Verfahren zur Herstellung von neuen, optisch aktiven Phenylisopropylaminderivaten

Legal Events

Date Code Title Description
PL Patent ceased